CANTILEVER INVESTORS — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Peptinovo develops PALM™, a targeted drug-delivery platform that encapsulates chemotherapy drugs to deliver them directly to cancer cells while sparing healthy tissue, reducing side effects and enabling higher therapeutic doses.
BiotechDeep TechHealthtechMedical DevicesAnn Arbor, US
Ren Homan(Founder)inREYNOLD HOMAN(Executive Officer, Director)BILL ELLIOTT(Executive Officer)inSTEVE TOKAZ(Executive Officer, Director)
BoardDAVID ROMENESCO(Director)FRED BROWN(Director)
Co-investorsID VenturesWMU Biosciences Research & Commercialization Center
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.